Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 5 Ovarian Neoplasms 2 Colorectal Neoplasms 2 Tuberous Sclerosis 1 Sarcoma 1 Pyloric Stenosis, Hypertrophic 1 Prostatic Neoplasms 1 Pediatric Solid Tumor 1 Pancreatic Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Melanoma 1 Lymphangioleiomyomatosis 1 Histiocytosis, Non-Langerhans-Cell 1 Histiocytosis, Langerhans-Cell 1 Hematologic Neoplasms 1 Glioma 1 Early Detection of Cancer 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Castleman Disease 1 Breast Screening 1 Breast Neoplasms, Male 1 Brain Neoplasms 1 Anatomic Stage II Breast Cancer AJCC v8 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

pembrolizumab 38 Bevacizumab 23 Cyclophosphamide 22 Standard of Care 18 Blood Specimen Collection 17 Carboplatin 16 Paclitaxel 15 Nivolumab 14 Gemcitabine 14 Pemetrexed 13 Exercise 13 Cisplatin 12 atezolizumab 11 Radiotherapy 11 Fluorouracil 11 Doxorubicin 11 Surveys and Questionnaires 9 Rituximab 9 Oxaliplatin 9 Magnetic Resonance Spectroscopy 9 Leucovorin 9 Cetuximab 9 Biopsy 9 130-nm albumin-bound paclitaxel 9 durvalumab 8 abemaciclib 8 Docetaxel 8 olaparib 7 Temozolomide 7 Prednisone 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Genetic Testing × 90 days × Clear all

NCT06008392 2026-04-07

INTERCEPTioN

Mayo Clinic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡